October 2013 - Volume 36 - Issue 8
pp: 391-458
Subscribe to eTOC

A Pan-Inhibitor of DASH Family Enzymes Induces Immune-mediated Regression of Murine Sarcoma and Is a Potent Adjuvant to Dendritic Cell Vaccination and Adoptive T-cell Therapy

Duncan, Brynn B.; Highfill, Steven L.; Qin, Haiying; More

Journal of Immunotherapy . 36(8):400-411, October 2013.


Phase II Trial of a GM-CSF-producing and CD40L-expressing Bystander Cell Line Combined With an Allogeneic Tumor Cell–based Vaccine for Refractory Lung Adenocarcinoma

Creelan, Ben C.; Antonia, Scott; Noyes, David; More

Journal of Immunotherapy . 36(8):442-450, October 2013.

IL-17A Promotes Immune Cell Recruitment in Human Esophageal Cancers and the Infiltrating Dendritic Cells Represent a Positive Prognostic Marker for Patient Survival

Lu, Lin; Pan, Ke; Zheng, Hai-Xia; More

Journal of Immunotherapy . 36(8):451-458, October 2013.